Systems | Development | Analytics | API | Testing

AI is now writing more of your code than ever. But the problem is that your test suite was built to catch errors, not to catch the difference between what an AI agent produced and what your original specification actually required. As AI tools accelerate development velocity, the volume of code moving through pipelines is outpacing traditional quality processes.

Chrome DevTools is the built-in browser inspector and debugger that ships with Google Chrome, giving testers ground-truth visibility into DOM state, network traffic, device rendering, and runtime behavior. In the context of Agentic Testing and QA — the emerging pattern where AI agents draft, execute, and summarize tests with reduced human supervision — DevTools remains the verification layer that confirms what an agent actually did inside the browser.

AI-assisted development means more code, faster release cycles, and a testing surface area that keeps expanding, but QA team size hasn't kept pace. The result is a pressure most QA engineers know well: you're not behind because you're slow. You're behind because the math no longer works. Most tools respond by adding AI at the margins: a suggestion feature here, a copilot shortcut there.

A working starter pack for finance and functional leaders — plus what to ask next once the conversation opens up.

A 90-day Agentic Testing and QA roadmap is a structured learning plan that combines daily JavaScript and TypeScript practice with hands-on Playwright automation and AI-assisted testing skills. It is built around three 30-day phases — language fundamentals, Playwright fundamentals, and advanced framework plus AI-oriented work — and assumes about one hour of practice per day.

Agentic AI is beginning to change how early-stage drug development really works by taking on the documentation burden that quietly slows innovation. In the U.S. biopharma ecosystem, the stakes couldn’t be higher. Bringing a new therapy from discovery to market often takes 10-15 years and can cost $2-3 billion per drug. At the same time, manufacturers are facing rising production costs, aggressive generic competition, and one of the most significant patent cliffs the industry has ever seen.

Everyone is talking about vibe coding—Claude Code, MCP, custom CLIs—using LLMs to turn intent into working logic. It’s fast. And if you aren’t leaning into it, you’re already behind. At Appian, we meet developers where they are. But speed alone doesn’t define success, and there’s a massive difference between a good workflow and a better one. Locking developers into one way of doing things is a losing strategy. That’s why we are releasing MCP and CLI tools.